The earnings call presented a strong performance with record revenue growth, increased profitability, successful international expansion, and continued brand recognition for FeraMAX. However, there are challenges with new product introductions and potential future impacts from trade tariffs. Overall, the positive highlights outweigh the lowlights.

Company Guidance -

Q2 2025

In the Q1 2025 results presentation, BioSyent Inc reported a significant financial performance, with revenues nearing $11 million, marking a 42% increase from the previous year. The company achieved a record quarter with a 45% increase in EBITDA, representing a 29% margin to revenue, and a net income after tax of over $2.3 million, which is 21% of revenue. The Canadian pharma business grew by 21% to nearly $9.2 million, while international pharmaceutical sales contributed over $1.5 million, a dramatic change from no sales in the comparable period. BioSyent's earnings per share saw a notable increase to $0.67 from $0.62 reported in the previous TTM period. Additionally, the company maintained a strong cash position of just under $25 million with no debt, and a return on equity that rose to 22% from 15% over the past year. A dividend of $0.05 was paid in March, an 11% increase from the prior year, and the company repurchased 19,500 shares year-to-date. BioSyent also emphasized its capital-light business model, ongoing investment in growth, and commitment to managing equity compensation in an anti-dilutive manner.

Record Revenue Growth

Revenue reached just under $11 million for Q1 2025, representing a 42% increase compared to the previous year and marking a record quarter for the company.

Strong Profitability and Shareholder Returns

EBITDA increased by 45%, net income after tax was over $2.3 million, and EPS rose to $0.67 from $0.62. The company also paid a dividend of $0.05, an 11% increase from the prior year.

Successful International Expansion

International pharmaceutical business generated over $1.5 million in sales, marking a shift from no sales in the previous comparable period.

FeraMAX Brand Recognition

FeraMAX was named the number one recommended oral iron supplement in Canada for the 10th consecutive year.

Strong Cash Position

The company reported just under $25 million in cash with no debt, maintaining a robust balance sheet.

Biosyent (TSE:RX) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

TSE:RX Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Aug 26, 2025	2025 (Q2)	- / -	0.13	―	―	―
May 15, 2025	2025 (Q1)	- / 0.20	0.15	33.33% (+0.05)	―	―
Mar 13, 2025	2024 (Q4)	0.15 / 0.14	0.12	16.67% (+0.02)	―	―
Nov 20, 2024	2024 (Q3)	0.14 / 0.20	0.2	0.00% (0.00)	―	―
Aug 26, 2024	2024 (Q2)	0.13 / 0.13	0.12	8.33% (+0.01)	―	―
May 16, 2024	2024 (Q1)	0.08 / 0.15	0.1	50.00% (+0.05)	―	―
Mar 13, 2024	2023 (Q4)	0.17 / 0.12	0.09	33.33% (+0.03)	―	―
Nov 16, 2023	2023 (Q3)	0.10 / 0.20	0.116	72.41% (+0.08)	―	―
Aug 22, 2023	2023 (Q2)	0.12 / 0.12	0.1	20.00% (+0.02)	―	―
May 26, 2023	2023 (Q1)	0.13 / 0.10	0.13	-23.08% (-0.03)	―	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

TSE:RX Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
May 15, 2025	C$10.72	C$11.70	+9.14%
Mar 13, 2025	C$10.75	C$11.15	+3.72%
Nov 20, 2024	C$10.77	C$11.16	+3.62%
Aug 26, 2024	C$10.04	C$10.42	+3.78%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Biosyent Inc (TSE:RX) report earnings?

Biosyent Inc (TSE:RX) is schdueled to report earning on Aug 26, 2025, TBA (Confirmed).

What is Biosyent Inc (TSE:RX) earnings time?

Biosyent Inc (TSE:RX) earnings time is at Aug 26, 2025, TBA (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is TSE:RX EPS forecast?

Currently, no data Available

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing